TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
35.07
+0.52 (1.51%)
At close: Nov 22, 2024, 4:00 PM
35.23
+0.16 (0.46%)
After-hours: Nov 22, 2024, 6:59 PM EST
TG Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -14.36 | 12.67 | -198.34 | -348.1 | -279.38 | -172.87 | Upgrade
|
| Depreciation & Amortization | 0.1 | 0.21 | 0.3 | 0.28 | 0.16 | 0.1 | Upgrade
|
| Other Amortization | 2.54 | 2.59 | 2.06 | 1.29 | 1.14 | 0.95 | Upgrade
|
| Loss (Gain) From Sale of Investments | -6.57 | -2.24 | -0.33 | 0.52 | -0.03 | -0.26 | Upgrade
|
| Stock-Based Compensation | 39.98 | 37.93 | 19.19 | 61.27 | 80.29 | 11.34 | Upgrade
|
| Other Operating Activities | 6.83 | 2.08 | 2.6 | 1.32 | 3.07 | 2.74 | Upgrade
|
| Change in Accounts Receivable | -76.41 | -51.09 | 1.39 | -1.39 | - | - | Upgrade
|
| Change in Inventory | -47.54 | -36.94 | - | - | - | - | Upgrade
|
| Change in Accounts Payable | 63.41 | 0.19 | -11.01 | 15.99 | 11.63 | -4.8 | Upgrade
|
| Change in Unearned Revenue | 18.32 | 5.71 | -0.15 | -0.15 | -0.15 | -0.15 | Upgrade
|
| Change in Other Net Operating Assets | -14.4 | -2.53 | 8.13 | -26.67 | -31.24 | 30.14 | Upgrade
|
| Operating Cash Flow | -28.09 | -31.41 | -176.17 | -295.63 | -214.51 | -132.81 | Upgrade
|
| Capital Expenditures | -0.02 | - | -0.01 | -0.4 | -0.36 | -0.13 | Upgrade
|
| Investment in Securities | -61.56 | -50.65 | -20 | 0.07 | -24.15 | -0.59 | Upgrade
|
| Investing Cash Flow | -61.58 | -50.65 | -20.01 | -0.33 | -24.51 | -0.72 | Upgrade
|
| Long-Term Debt Issued | - | 25 | - | 70 | - | 29.99 | Upgrade
|
| Long-Term Debt Repaid | - | - | -0.98 | -30 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 137.26 | 25 | -0.98 | 40 | - | 29.99 | Upgrade
|
| Issuance of Common Stock | 0.34 | 47.83 | 0.58 | 2.44 | 679.83 | 175.02 | Upgrade
|
| Repurchase of Common Stock | -2.15 | - | - | - | - | - | Upgrade
|
| Other Financing Activities | -0.86 | -0.13 | - | -1.02 | - | -0.8 | Upgrade
|
| Financing Cash Flow | 134.6 | 72.71 | -0.39 | 41.42 | 679.83 | 204.21 | Upgrade
|
| Net Cash Flow | 44.93 | -9.36 | -196.57 | -254.55 | 440.81 | 70.69 | Upgrade
|
| Free Cash Flow | -28.11 | -31.41 | -176.18 | -296.04 | -214.86 | -132.94 | Upgrade
|
| Free Cash Flow Margin | -10.62% | -13.44% | -6326.18% | -4425.70% | -141357.89% | -87458.55% | Upgrade
|
| Free Cash Flow Per Share | -0.19 | -0.21 | -1.30 | -2.24 | -1.86 | -1.50 | Upgrade
|
| Cash Interest Paid | 16.89 | 8.77 | 5.45 | 3.47 | 4.5 | 2.62 | Upgrade
|
| Levered Free Cash Flow | -45.57 | -47.55 | -106.99 | -166.6 | -111.19 | -51.34 | Upgrade
|
| Unlevered Free Cash Flow | -35.78 | -42.05 | -102.47 | -164.16 | -108.16 | -48.8 | Upgrade
|
| Change in Net Working Capital | 75.73 | 93.3 | 1.63 | 10.04 | 17.47 | -45.27 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.